Valeant Submits Merger Proposal to Allergan Board
April 22, 2014 at 07:43 AM EDT
Developing: Valeant Pharmaceuticals said Tuesday it submitted a merger proposal to Allergan’s board to exchange each Allergan share for $48.30 cash and .83 shares of Valeant common stock.
